Patents by Inventor Paul Menkin

Paul Menkin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diketopiperazine Microparticles with Defined Specific Surface Areas
    Publication number: 20230181573
    Abstract: Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m2/g. The diketopiperazine microparticle can be fumaryl diketopiperazine and can comprise a drug such as insulin.
    Type: Application
    Filed: February 7, 2023
    Publication date: June 15, 2023
    Inventors: Marshall L. Grant, Grayson W. Stowell, Paul Menkin, John J. Freeman, JR.
  • Diketopiperazine microparticles with defined specific surface areas
    Patent number: 11607410
    Abstract: Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m2/g. The diketopiperazine microparticle can be fumaryl diketopiperazine and can comprise a drug such as insulin.
    Type: Grant
    Filed: August 14, 2020
    Date of Patent: March 21, 2023
    Assignee: MannKind Corporation
    Inventors: Marshall L. Grant, Grayson W. Stowell, Paul Menkin, John J. Freeman, Jr.
  • HIGH CAPACITY DIKETOPIPERAZINE MICROPARTICLES AND METHODS
    Publication number: 20230016875
    Abstract: Disclosed herein are diketopiperazine microparticles having high capacity for adsorbing a drug or active agent. In particular, the diketopiperazine microparticle are formed using fumaryl diketopiperazine and can comprise a drug in large doses for the treatment of disease or disorders by pulmonary delivery via oral inhalation.
    Type: Application
    Filed: July 26, 2022
    Publication date: January 19, 2023
    Applicant: MannKind Corporation
    Inventors: Marshall Grant, Paul Menkin, Grayson W. Stowell
  • High capacity diketopiperazine microparticles and methods
    Patent number: 11433135
    Abstract: Disclosed herein are diketopiperazine microparticles having high capacity for adsorbing a drug or active agent. In particular, the diketopiperazine microparticle are formed using fumaryl diketopiperazine and can comprise a drug in large doses for the treatment of disease or disorders by pulmonary delivery via oral inhalation.
    Type: Grant
    Filed: January 10, 2020
    Date of Patent: September 6, 2022
    Assignee: MannKind Corporation
    Inventors: Marshall Grant, Paul Menkin, Grayson W. Stowell
  • Diketopiperazine Microparticles with Defined Specific Surface Areas
    Publication number: 20200375984
    Abstract: Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m2/g. The diketopiperazine microparticle can be fumaryl diketopiperazine and can comprise a drug such as insulin.
    Type: Application
    Filed: August 14, 2020
    Publication date: December 3, 2020
    Inventors: Marshall L. Grant, Grayson W. Stowell, Paul Menkin, John J. Freeman, JR.
  • Diketopiperazine microparticles with defined specific surface areas
    Patent number: 10772883
    Abstract: Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m2/g. The diketopiperazine microparticle can be fumaryl diketopiperazine and can comprise a drug such as insulin.
    Type: Grant
    Filed: March 17, 2017
    Date of Patent: September 15, 2020
    Assignee: MannKind Corporation
    Inventors: Marshall L. Grant, Grayson W. Stowell, Paul Menkin, John J. Freeman, Jr.
  • HIGH CAPACITY DIKETOPIPERAZINE MICROPARTICLES AND METHODS
    Publication number: 20200147221
    Abstract: Disclosed herein are diketopiperazine microparticles having high capacity for adsorbing a drug or active agent. In particular, the diketopiperazine microparticle are formed using fumaryl diketopiperazine and can comprise a drug in large doses for the treatment of disease or disorders by pulmonary delivery via oral inhalation.
    Type: Application
    Filed: January 10, 2020
    Publication date: May 14, 2020
    Applicant: MannKind Corporation
    Inventors: Marshall Grant, Paul Menkin, Grayson W. Stowell
  • High capacity diketopiperazine microparticles and methods
    Patent number: 10603383
    Abstract: Disclosed herein are diketopiperazine microparticles having high capacity for adsorbing a drug or active agent. In particular, the diketopiperazine microparticle are formed using fumaryl diketopiperazine and can comprise a drug in large doses for the treatment of disease or disorders by pulmonary delivery via oral inhalation.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: March 31, 2020
    Assignee: MannKind Corporation
    Inventors: Marshall Grant, Paul Menkin, Grayson W. Stowell
  • HIGH CAPACITY DIKETOPIPERAZINE MICROPARTICLES AND METHODS
    Publication number: 20190336606
    Abstract: Disclosed herein are diketopiperazine microparticles having high capacity for adsorbing a drug or active agent. In particular, the diketopiperazine microparticle are formed using fumaryl diketopiperazine and can comprise a drug in large doses for the treatment of disease or disorders by pulmonary delivery via oral inhalation.
    Type: Application
    Filed: June 26, 2019
    Publication date: November 7, 2019
    Applicant: MannKind Corporation
    Inventors: Marshall Grant, Paul Menkin, Grayson W. Stowell
  • High capacity diketopiperazine microparticles and methods
    Patent number: 10376587
    Abstract: Disclosed herein are diketopiperazine microparticles having high capacity for adsorbing a drug or active agent. In particular, the diketopiperazine microparticle are formed using fumaryl diketopiperazine and can comprise a drug in large doses for the treatment of disease or disorders by pulmonary delivery via oral inhalation.
    Type: Grant
    Filed: October 4, 2018
    Date of Patent: August 13, 2019
    Assignee: MannKind Corporation
    Inventors: Marshall Grant, Paul Menkin, Grayson W. Stowell
  • HIGH CAPACITY DIKETOPIPERAZINE MICROPARTICLES AND METHODS
    Publication number: 20190076530
    Abstract: Disclosed herein are diketopiperazine microparticles having high capacity for adsorbing a drug or active agent. In particular, the diketopiperazine microparticle are formed using fumaryl diketopiperazine and can comprise a drug in large doses for the treatment of disease or disorders by pulmonary delivery via oral inhalation.
    Type: Application
    Filed: October 4, 2018
    Publication date: March 14, 2019
    Inventors: Marshall Grant, Paul Menkin, Grayson W. Stowell
  • High capacity diketopiperazine microparticles and methods
    Patent number: 10130709
    Abstract: Disclosed herein are diketopiperazine microparticles having high capacity for adsorbing a drug or active agent. In particular, the diketopiperazine microparticle are formed using fumaryl diketopiperazine and can comprise a drug in large doses for the treatment of disease or disorders by pulmonary delivery via oral inhalation.
    Type: Grant
    Filed: May 11, 2016
    Date of Patent: November 20, 2018
    Assignee: MannKind Corporation
    Inventors: Marshall Grant, Paul Menkin, Grayson W. Stowell
  • DIKETOPIPERAZINE MICROPARTICLES WITH DEFINED SPECIFIC SURFACE AREAS
    Publication number: 20170189395
    Abstract: Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m2/g. The diketopiperazine microparticle can be fumaryl diketopiperazine and can comprise a drug such as insulin.
    Type: Application
    Filed: March 17, 2017
    Publication date: July 6, 2017
    Inventors: Marshall L. Grant, Grayson W. Stowell, Paul Menkin, John J. Freeman, JR.
  • Diketopiperazine microparticles with defined specific surface areas
    Patent number: 9630930
    Abstract: Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m2/g. The diketopiperazine microparticle can be fumaryl diketopiperazine and can comprise a drug such as insulin.
    Type: Grant
    Filed: April 11, 2014
    Date of Patent: April 25, 2017
    Assignee: MannKind Corporation
    Inventors: Marshall L. Grant, Grayson W. Stowell, Paul Menkin
  • HIGH CAPACITY DIKETOPIPERAZINE MICROPARTICLES AND METHODS
    Publication number: 20160346394
    Abstract: Disclosed herein are diketopiperazine microparticles having high capacity for adsorbing a drug or active agent. In particular, the diketopiperazine microparticle are formed using fumaryl diketopiperazine and can comprise a drug in large doses for the treatment of disease or disorders by pulmonary delivery via oral inhalation.
    Type: Application
    Filed: May 11, 2016
    Publication date: December 1, 2016
    Inventors: Marshall Grant, Paul Menkin, Grayson W. Stowell
  • High capacity diketopiperazine microparticles and methods
    Patent number: 9364436
    Abstract: Disclosed herein are diketopiperazine microparticles having high capacity for adsorbing a drug or active agent. In particular, the diketopiperazine microparticle are formed using fumaryl diketopiperazine and can comprise a drug in large doses for the treatment of disease or disorders by pulmonary delivery via oral inhalation.
    Type: Grant
    Filed: June 18, 2012
    Date of Patent: June 14, 2016
    Assignee: MannKind Corporation
    Inventors: Marshall Grant, Paul Menkin, Grayson W. Stowell
  • DIKETOPIPERAZINE MICROPARTICLES WITH DEFINED SPECIFIC SURFACE AREAS
    Publication number: 20140271888
    Abstract: Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m2/g. The diketopiperazine microparticle can be fumaryl diketopiperazine and can comprise a drug such as insulin.
    Type: Application
    Filed: April 11, 2014
    Publication date: September 18, 2014
    Applicant: MannKind Corporation
    Inventors: Marshall L. Grant, Grayson W. Stowell, Paul Menkin
  • HIGH CAPACITY DIEKTOPIPERAZINE MICROPARTICLES AND METHODS
    Publication number: 20140199398
    Abstract: Disclosed herein are diketopiperazine microparticles having high capacity for adsorbing a drug or active agent. In particular, the diketopiperazine microparticle are formed using fumaryl diketopiperazine and can comprise a drug in large doses for the treatment of disease or disorders by pulmonary delivery via oral inhalation.
    Type: Application
    Filed: June 18, 2012
    Publication date: July 17, 2014
    Applicant: MANNKIND CORPORATION
    Inventors: Marshall Grant, Paul Menkin, Grayson W. Stowell
  • Diketopiperazine microparticles with defined specific surface areas
    Patent number: 8778403
    Abstract: Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m2/g. The diketopiperazine microparticle can be fumaryl diketopiperazine and can comprise a drug such as insulin.
    Type: Grant
    Filed: September 3, 2013
    Date of Patent: July 15, 2014
    Assignee: Mannkind Corporation
    Inventors: Marshall L. Grant, Grayson W. Stowell, Paul Menkin
  • Diketopiperazine microparticles with defined specific surface areas
    Patent number: 8734845
    Abstract: Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m2/g. The diketopiperazine microparticle can be fumaryl diketopiperazine and can comprise a drug such as insulin.
    Type: Grant
    Filed: June 11, 2010
    Date of Patent: May 27, 2014
    Assignee: Mannkind Corporation
    Inventors: Marshall L. Grant, Grayson W. Stowell, Paul Menkin